Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004969579 | SCV005525473 | uncertain significance | Inborn genetic diseases | 2024-11-14 | criteria provided, single submitter | clinical testing | The c.700C>A (p.Q234K) alteration is located in exon 2 (coding exon 2) of the TTI2 gene. This alteration results from a C to A substitution at nucleotide position 700, causing the glutamine (Q) at amino acid position 234 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |